FDA Approves New Osteoporosis Treatment Evenity (romosozumab)

TUESDAY, April 9, 2019 — Many aging Americans face the risk of fractures due to osteoporosis. Now, they have a new means of fighting back, thanks to the U.S. Food and Drug Administration’s approval of a new treatment on Tuesday.
The FDA gave its…
Source: Topamax